FINE Gael Innovation and Research Spokesperson Deirdre Clune TD has expressed her disappointment at the announcement of 55 job losses at GlaxoSmithKline (GSK) in Cork together with changes to shift patterns which will result in 66 fewer jobs.
The Cork TD criticised the Government for the lack of any credible job creation policy and its inability to improve Irish competitiveness.
“This announcement at GSK in Cork is just the latest in a long line of job losses in the pharmaceutical industry. Just last month Schering-Plough, a pharmaceutical company with over 30 years of history in Cork, announced 160 job losses. Earlier this year Pfizer announced 785 job losses in Ireland.
“These major job losses are the result of global cost reviews in which Ireland’s competitiveness problems have sent out major negative signals.
“Last month the World Economic Forum announced that Ireland has slipped from the 25th most competitive economy in the world last year to the 29th this year. The Government’s response was to ignore the problem.
“Just before the Dáil resumed, the CSO announced that 450,000 people were on the Live Register in September. The Government’s response was to hope that 300,000 new jobs may be found to solve the problem, but neither Fianna Fáil nor the Greens have done anything to make this a reality.
“This Government’s only priority is to keep itself in power and avoid an election which may result in mass unemployment among Green and Fianna Fáil TDs.”